Product Information

LEVOTHYROXINE 137 MCG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0627 per EA under NDC 00378182310. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jun 5, 2002. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3,AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOTHYROXINE 137 MCG TABLET

levothyroxine sodium
$0.0627per EA

Strength

137 ug/1

NDC

00378182310

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA076187

FDA Approved

6/5/2002

TE Code

AB1,AB2,AB3,AB4

On Market Since

12/15/2006

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOTHYROXINE 137 MCG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 78.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0627 per EA
All-time high$0.5375 (Oct 15, 2014)
All-time low$0.0555 (Jul 17, 2024)
52-week high$0.0755
52-week low$0.0624
Median price$0.3443
Average price$0.3089
Largest weekly change+51.0% (Jun 19, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.6%

1M

-0.3%

3M

-2.4%

6M

-10.6%

1Y

-15.0%

3Y

-51.1%

5Y

-78.8%

All

-78.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LEVOTHYROXINE 137 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 137 MCG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0627 per EA (NDC 00378182310), effective Aug 19, 2026.

How has the price of LEVOTHYROXINE 137 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOTHYROXINE 137 MCG TABLET has declined 78.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 137 MCG TABLET?

Since Nov 28, 2013, the NADAC for LEVOTHYROXINE 137 MCG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.5375 (Oct 15, 2014), with a median of $0.3443 per EA.

Are there cheaper alternatives to LEVOTHYROXINE 137 MCG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 137 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LEVOTHYROXINE 137 MCG TABLET?

LEVOTHYROXINE 137 MCG TABLET (NDC 00378182310) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.